Long-term outcomes after transmyocardial revascularization.

[1]  Adrian F Hernandez,et al.  Linking inpatient clinical registry data to Medicare claims data using indirect identifiers. , 2009, American heart journal.

[2]  R. Guyton,et al.  Impact of unstable angina on outcomes of transmyocardial laser revascularization combined with coronary artery bypass grafting. , 2005, The Annals of thoracic surgery.

[3]  P. Armstrong,et al.  From controlled trials to clinical practice: monitoring transmyocardial revascularization use and outcomes. , 2003, Journal of the American College of Cardiology.

[4]  K. Rootwelt,et al.  Continued symptomatic improvement three to five years after transmyocardial revascularization with CO(2) laser: a late clinical follow-up of the Norwegian Randomized trial with transmyocardial revascularization. , 2002, Journal of the American College of Cardiology.

[5]  B. Griffith,et al.  Sustained Angina Relief 5 Years After Transmyocardial Laser Revascularization With a CO2 Laser , 2001, Circulation.

[6]  F. Mohr,et al.  Transmyocardial laser revascularization with the holmium:YAG laser: loss of symptomatic improvement after 2 years. , 2001, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[7]  K. Endresen,et al.  Transmyocardial Revascularization Transmyocardial Revascularization With CO 2 Laser in Patients With Refractory Angina Pectoris Clinical Results from The Norwegian Randomized Trial , 2016 .

[8]  J. Lowe,et al.  Early postoperative changes in regional systolic and diastolic left ventricular function after transmyocardial laser revascularization: a comparison of holmium:YAG and CO2 lasers. , 2000, Journal of the American College of Cardiology.

[9]  R. Dowling,et al.  Transmyocardial laser revascularization combined with coronary artery bypass grafting: a multicenter, blinded, prospective, randomized, controlled trial. , 2000, The Journal of thoracic and cardiovascular surgery.

[10]  O. Frazier,et al.  Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease. , 1999, The New England journal of medicine.

[11]  Robert D. Dowling,et al.  Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina. , 1999, The New England journal of medicine.

[12]  Daniel Burkhoff,et al.  Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomised trial , 1999, The Lancet.

[13]  M. Nakamura,et al.  Experimental investigations on relationships between myocardial damage and laser type used in transmyocardial laser revascularization (TMLR). , 1999, The Kobe journal of medical sciences.

[14]  James W. Jones,et al.  Holmium:YAG laser transmyocardial revascularization relieves angina and improves functional status. , 1999, The Annals of thoracic surgery.

[15]  L. Sharples,et al.  Transmyocardial laser revascularisation in patients with refractory angina: a randomised controlled trial , 1999, The Lancet.

[16]  D. Burkhoff,et al.  Histologic analysis of transmyocardial channels: comparison of CO2 and holmium:YAG lasers. , 1997, The Annals of thoracic surgery.

[17]  Z. Ying,et al.  Checking the Cox model with cumulative sums of martingale-based residuals , 1993 .

[18]  J. Kalbfleisch,et al.  The Statistical Analysis of Failure Time Data , 1980 .

[19]  D. Cox.  Regression Models and Life-Tables , 1972 .